Abstract
This work concerns study of self-absorption factor (SAF) and dose rate constants of zirconium-89 (Zr-89) for the purpose of radiation protection in positron emission tomography (PET) and to compare them with those of F-18-deoxyglucose (F-18-FDG). We analyzed the emitted energy spectra by F-18 and Zr-89 through anthropomorphic phantom and calculated the absorbed energy using Monte Carlo method. The dose rate constants for both radionuclides were estimated with 2 different fluence-to-effective dose conversion coefficients. Our estimated SAF value of 0.65 for F-18 agreed with the recommendation of the American Association of Physicists in Medicine (AAPM). The SAF for Zr-89 was in the range of 0.61-0.66 depending on the biodistribution. Using the fluence-to-effective dose conversion coefficients recommended jointly by the American National Standards Institute and the American Nuclear Society (ANSI/ANS), the dose rate at 1 m from the patient for F-18 was 0.143 mu Sv center dot MBq(-1)center dot hr(-1), which is consistent with the AAPM recommendation, while that for Zr-89 was 0.154 mu Sv center dot MBq(-1)center dot hr(-1). With the conversion coefficients currently recommended by the International Committee on Radiological Protection (ICRP), the dose rate estimates were lowered by 2.8% and 2.6% for Zr-89 and F-18, respectively. Also, we observed that the AAPM derived dose is an overestimation near the patient, compared to our simulations, which can be explained by the biodistribution nature and the assumption of the point source. Thus, we proposed new radiation protection factors for Zr-89 radionuclide.